U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07222917) titled 'A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.' on Oct. 17.
Brief Summary: International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.
Study Start Date: Dec. 05
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease and Hypertension
Intervention:
DRUG: Baxdrostat/...